[INCINTA U.S. News Update] Excellence Forged Through Rigorous Accreditation | INCINTA Laboratory Achieves Industry’s ‘Gold Standard’ CAP Accreditation

On February 13, 2025, INCINTA Laboratory reached a milestone moment: achieving the internationally renowned College of American Pathologists (CAP) accreditation—recognized as the industry’s ‘gold standard’—with zero deficiencies across all evaluated domains.

On February 13, 2025, INCINTA Laboratory reached a milestone moment: achieving the internationally renowned College of American Pathologists (CAP) accreditation—recognized as the industry’s ‘gold standard’—with zero deficiencies across all evaluated domains.

CAP Accreditation: The Highest Industry Recognition of the ‘Gold Standard’

CAP—the world’s largest organization of board-certified pathologists—holds exceptional authority and credibility in international clinical laboratory accreditation. It is widely regarded as the ‘gold standard’ for laboratory certification. Its accreditation program is distinguished by comprehensive, rigorous inspection protocols; its laboratory quality standards are deemed by the U.S. government to hold equivalent legal weight to federal certification programs—and in certain aspects, impose even stricter requirements. CAP mandates not only cutting-edge technical capability but also stringent criteria across critical dimensions including quality management, staff training, and operational procedures—all designed to ensure laboratories deliver high-quality, reliable diagnostic services to patients.

INCINTA Laboratory’s achievement of CAP accreditation signifies that its technical expertise and management systems meet or exceed CAP’s highest benchmarks. It fully aligns with industry best practices and regulatory requirements—and consistently upholds excellence in patient care. This accreditation represents both a profound validation of INCINTA’s current accomplishments and a solid foundation for its future growth.

High Praise from Accreditation Reviewers: Professional Recognition of Exceptional Capability

The CAP accreditation review was led by Dr. David Battaglia, Professor at Oregon Health & Science University and Director of a renowned reproductive medicine laboratory. Notably, he was the first reproductive medicine specialist worldwide to successfully culture blastocysts from thawed oocytes and achieve live births—a pioneering contribution reflecting his deep expertise and extensive experience in reproductive medicine.

Applying CAP’s official accreditation criteria, Dr. David Battaglia conducted a thorough, in-depth, and meticulous evaluation of INCINTA Laboratory—from its state-of-the-art infrastructure and seamless teamwork among laboratory personnel, to its robust quality management system. No detail escaped his expert scrutiny.

Following this rigorous and exhaustive review process, Dr. David Battaglia offered INCINTA Laboratory unequivocal praise and strong endorsement. He remarked: “Of the 58 IVF laboratories I have inspected, INCINTA is unquestionably the finest reproductive center I have ever reviewed—truly a source of great personal joy. This is an outstanding laboratory: its staff are exceptionally well-trained, deeply committed to patient-centered care, and enthusiastically embrace emerging technologies—all of which left a profoundly lasting impression on me.”

Looking Ahead: Staying True to Our Mission, Upholding Family Trust

Dr. Xie, Director of INCINTA Laboratory, stated that successful CAP accreditation marks another pivotal milestone in the laboratory’s development journey. This honor not only affirms the sustained dedication and hard work of every team member but also powerfully propels INCINTA’s future advancement.

[图片:https://cdn.yun.sooce.cn/6/59417/png/1748511924391cd1625f45c8aa7ddf9ef40b7821397c5.png?version=1748511927][INCINTA Laboratory team photo]

Moving forward, INCINTA Laboratory will continue adhering to the highest standards and strictest requirements—continuously enhancing its technical capabilities and professional expertise. Leveraging the power of science, it will safeguard the trust placed in it by every family, delivering premium, reliable diagnostic services to more individuals and couples in need—and helping them realize their dreams of parenthood, one beautiful life story at a time.

This article is a public-information summary published by WFA. It is intended for industry, media and the general public, and does not constitute medical or investment advice.